RAY-121 is under clinical development by Chugai Pharmaceutical and currently in Phase I for Antiphospholipid Syndrome.

Catastrophic antiphospholipid syndrome (CAPS) is a rare and life threatening complication of antiphospholipid syndrome. Up to half of people with CAPS die, so timely treatment is essential.

YTS-109 is under clinical development by Bristar Immunotech Biotechnology and currently in Phase I for Polymyositis.

The antiphospholipid syndrome associated with hepatic vein thrombosis has usually been of the primary type; that is, the American Rheumatism Association criteria for the diagnosis of systemic ...

"I was then asked to leave the room, Aaliyah's pulse was lost, and a code blue was called," the twins' dad told Newsweek.

Currently, doctors think he is suffering from Antiphospholipid syndrome (APS). It is what it is at this point- the spasticity has gone from his hand and it’s all just down to fine-tuning now but it’s ...

For the present ... we will continue to treat pregnant APS patients with heparin and LDA Importantly, the findings underscore the lack of effective therapies to prevent pregnancy loss in patients ...

Antiphospholipid antibody syndrome (APS) is a rare autoimmune condition that causes thickening of the circulating blood. APS is estimated to affect one in 2,000 people in the United States alone.

1. What is antiphospholipid syndrome (APS)? Antiphospholipid syndrome (APS) is a systemic autoimmune disorder in which the patient’s immune system makes antibodies (antiphospholipid antibodies [aPL]) ...

Objectives To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the frequency of early manifestations ...

Objectives Antiphospholipid syndrome (APS) is characterised by the presence of antiphospholipid antibodies (aPLs) and clinical outcomes of thrombosis and/or obstetric morbidity and is associated with ...